Sign up to get full access to all our latest press releases and newsletters.
Sign UpNovember 10th, 2023
Organigram Announces Interim Chief Financial Officer
November 6th, 2023
Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool
October 18th, 2023
Organigram Provides Corporate Update Achieves #2 Market Share Over the Last Two Months
October 12th, 2023
Organigram Holdings Inc. Files Final Base Shelf Prospectus
September 26th, 2023
Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus
September 1st, 2023
Organigram Announces Resignation of Board Member
August 28th, 2023
Organigram Launches First Range of THCV Products Derived from Moncton- Grown Whole Flower
August 15th, 2023
Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS
July 13th, 2023
Organigram Reports Third Quarter Fiscal 2023 Results
July 6th, 2023
Organigram Announces Completion of Share Consolidation
June 20th, 2023
Organigram Announces Effective Date of Share Consolidation
May 25th, 2023
Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production
May 23rd, 2023